<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.ivybraintumorcenter.org/es/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/ribociclib-mas-everolimus-para-el-glioma-de-alto-grado-recurrente/</loc>
		<lastmod>2023-08-02T23:24:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/ribociclib-para-meningioma-recurrente/</loc>
		<lastmod>2023-08-02T23:25:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/ribociclib-para-glioblastoma-recurrente/</loc>
		<lastmod>2023-08-02T23:25:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/niraparib-para-glioblastoma-diagnosticado-recientemente/</loc>
		<lastmod>2023-08-02T23:28:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/superselective-high-grade-glioma-clinical-trial/</loc>
		<lastmod>2023-08-02T23:29:59+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2023/08/iStock-1158816802-resized-1024x418-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/10/Team-Headshot-Hexagon_4.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/10/Jenny-Headshot-Hexagon.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2020/06/How-it-works_2@4x.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/10/Team-Headshot-Hexagon_5.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/infigratinib-para-pacientes-con-glioblastoma-recurrente/</loc>
		<lastmod>2023-08-02T23:38:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/ensayo-clinico-de-fase-1-2-de-terapia-sonodinamica-para-glioblastoma-recurrente/</loc>
		<lastmod>2023-08-02T23:43:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/azd1390-para-el-glioma-recurrente-de-grado-iv/</loc>
		<lastmod>2023-08-02T23:50:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/terapia-sonodinamica-en-glioma-de-alto-grado-recurrente/</loc>
		<lastmod>2023-08-02T23:54:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/pamiparib-para-glioblastoma-diagnosticado-recientemente-o-recurrente/</loc>
		<lastmod>2023-08-02T23:59:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/radioterapia-vs-observacion-para-meningioma-de-nuevo-diagnostico/</loc>
		<lastmod>2023-08-03T00:32:00+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2023/08/image-5.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2023/08/image-6.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/radioterapia-para-el-glioma-anaplasico-recientemente-diagnosticado/</loc>
		<lastmod>2023-08-03T00:33:21+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2023/08/image-3.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/dsc-mri-para-glioblastoma-recurrente/</loc>
		<lastmod>2023-08-03T00:40:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/planificacion-de-la-radioterapia-con-fluciclovine-pet-para-el-glioblastoma-recien-diagnosticado/</loc>
		<lastmod>2023-08-03T00:47:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/radioterapia-para-metastasis-cerebral/</loc>
		<lastmod>2023-08-03T00:53:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/inhibidores-de-smo-akt-nf2-cdk-para-meningiomas-progresivos/</loc>
		<lastmod>2023-08-03T00:58:09+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2023/08/image-14.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/safusidenib-ab-218-para-glioma-mutante-idh1/</loc>
		<lastmod>2023-08-03T01:03:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/onc201-en-glioma-difuso-con-mutacion-h3-k27m-recien-diagnosticado/</loc>
		<lastmod>2024-04-17T17:59:22+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/03/ONC-201_ES_Featured-Image-scaled.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/10/Jenny-Headshot-Hexagon.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/02/Ivy_Web_Icon_Phase3-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/02/How-it-works_3@4x-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/10/Team-Headshot-Hexagon_5.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/ensayos-clinicos-de-tumores-cerebrales/current-trials/bdtx-1535-para-glioma-de-alto-grado-recurrente/</loc>
		<lastmod>2024-07-16T17:14:20+00:00</lastmod>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/03/BDTX-Landing-Page-featured-image-scaled.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/03/How-it-works_1@4x-2.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/03/How-it-works_2@4x-5.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/03/How-it-works_3@4x-3.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://www.ivybraintumorcenter.org/es/wp-content/uploads/sites/2/2024/03/How-it-works_4@4x-2.png</image:loc>
		</image:image>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->